ADVERTISEMENT
illustration of a coronavirus and antibodies
When the Immune Response Makes COVID-19 Worse
If the immune system makes mistakes—reacting late or getting the target wrong—it can amplify the damage wrought by SARS-CoV-2.
When the Immune Response Makes COVID-19 Worse
When the Immune Response Makes COVID-19 Worse

If the immune system makes mistakes—reacting late or getting the target wrong—it can amplify the damage wrought by SARS-CoV-2.

If the immune system makes mistakes—reacting late or getting the target wrong—it can amplify the damage wrought by SARS-CoV-2.

antibodies, disease & medicine, microbiology

An illustration of several human heads wearing masks
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021 | 4 min read
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021 | 6 min read
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
COVID-19, SARS-CoV-2, pandemic, research, reverse genetics, toolkit, antibodies, RNA
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021 | 6 min read
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
regeneron monoclonal antibody sars-cov-2 covid-19 pandemic coronavirus neutralization b.1.351 variant south africa REGN10987 casirivimab and REGN10933 imdevimab
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021 | 3 min read
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
special report
How (Not) to Do an Antibody Survey for SARS-CoV-2
Catherine Offord | Apr 28, 2020 | 10+ min read
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020 | 3 min read
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  
Commensal Mimicry in Autoimmune Disease
Infographic: Commensal Mimicry in Autoimmune Disease
Amanda B. Keener | Jun 1, 2019 | 1 min read
Antigens originating from the microbiome may trigger an autoimmune response.
ADVERTISEMENT